(855) 264-3218Clinical Trials
AnidasoHub

Clinical research study

New York, NY

Severe Asthma · Phase 3

Severe Uncontrolled Asthma Study

PIONEER CLINICAL RESEARCH NY
Public Disclosure
About this study

This study is testing whether GB-0895, a new add-on treatment, can better control asthma in people whose symptoms remain serious even while using multiple inhalers. It may help adolescents and adults who have had two or more asthma flare-ups in the past year despite taking high-dose inhaled steroids. Taking part involves being randomly assigned to receive either GB-0895 or a placebo alongside your current asthma medicines. Study visits will track how your breathing and symptoms respond over time.

Key criteria
  • Ages 12 to 80
  • Asthma diagnosis for at least 2 years
  • On medium- or high-dose inhaled steroids plus at least one other controller
  • Two or more asthma flare-ups in the past 12 months
  • Asthma not fully controlled on current medicines

A few of the main points — Anida will check the rest with you.

Check if you may be a match

Anida asks a few questions to see whether you may be a fit — free & private. Nothing is shared with a research site unless you choose to.

Know someone who might be interested? Pass it on.